Zenlabs Ethica Limited Share Price

Zenlabs Ethica Limited Share Price

BSE: 530697
|
Trading
₹ 28.00
-₹1.05 (-3.61%)
1D
Last updated 24 Jul, 2026, 14:37 IST

Zenlabs Ethica Limited Share Price Today

As of 25 Jul 2026, Zenlabs Ethica Limited share price is ₹28.00. The stock opened at ₹29.34, compared to its previous close of ₹29.05. During today's trading session, Zenlabs Ethica Limited share price moved in the range of ₹27.60 to ₹29.34, with an average price of ₹28.47 for the day. Looking at its last 52-week, the stock has touched a low of ₹16.50 and a high of ₹39.99.

₹27.60
3.61% down today
₹29.34
1D LOW
1D HIGH

Zenlabs Ethica Limited Returns Calculator

Circuit
L
H
₹26.60
₹29.40
52-week
L
H
₹16.50
₹39.99
Mkt Cap Cr
18.23
P/E
-9.43
P/B
2.14
ROE
0.23%
D/E
1.29
ROCE
5.22%
Div. Yield
0.00%
EPS(TTM)
-2.97
Turnover
4.65
EV/EBITDA
-269.81
Net Margin
0.00%
Op. Margin
0.00%
ROA
-5.21%
Quick Ratio
0.00
Curr. Ratio
2.11
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Zenlabs Ethica has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Zenlabs Ethica appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,88,655.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.963.3111.27%0.0014.95%423.360.92%0.4543.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,03,472.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories96,204.7030.222.5311.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.392.359.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs86,564.2079.3616.3316.77%0.4016.14%97.210.12%0.6413.72

Zenlabs Ethica Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹51.42₹58.56₹66.89₹69.09
Other Income₹0.05₹0.30₹0.13₹0.09
Total Revenue₹51.47₹58.86₹67.01₹69.18
Total Expenses₹51.04₹58.28₹65.77₹67.95
Profit Before Tax₹0.43₹0.58₹0.67₹1.22
Tax₹0.16₹0.16₹0.19₹0.44
Profit After Tax₹0.27₹0.42₹0.49₹0.78
EPS - Basic₹0.41₹0.65₹0.75₹1.20
EPS - Diluted₹0.41₹0.65₹0.75₹1.20

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹0.43₹0.58₹0.67₹1.22
Income before WC changes₹2.70₹2.69₹2.95₹2.40
Change in Assets-₹1.00₹1.13-₹4.56-₹6.02
Change in Liabilities₹2.34-₹12.75₹3.40₹3.36
Change in WC₹1.34-₹11.62-₹1.17-₹2.66
Cash flow from Operations₹3.83-₹9.06₹1.52-₹0.38
Cash flow from Investing₹0.14₹0.11-₹1.47₹0.00
Cash flow from Financing-₹3.08₹8.24₹0.06₹0.31
Total Cash Flow₹0.88-₹0.71₹0.11-₹0.07
Cash (Start of the year)₹0.91₹1.62₹1.51₹1.57
Cash (End of the year)₹1.79₹0.91₹1.62₹1.51

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹3.27₹4.71₹5.99₹4.50
Current Assets₹37.35₹35.55₹37.50₹33.40
Total Assets₹40.62₹40.26₹43.49₹37.90
Current Liabilities₹28.12₹27.02₹29.45₹25.20
Net Current Asset₹9.23₹8.52₹8.05₹8.20
Non-Current Liabilities₹2.07₹3.11₹4.34₹3.36
Equity Capital₹10.43₹10.12₹9.70₹9.33
Total Equity & Liabilities₹40.62₹40.26₹43.49₹37.90
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
36.04
Neutral
ATR (14)
1.61
Neutral
STOCH(9,6)
6.78
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
43.78
Bearish
UO(9)
40.98
Neutral
ROC(12)
-13.29
Bearish
WillR(14)
-94.48
Bullish
Period
Simple value
Exponential vaue
5D
29.45
29.48
10D
31.08
30.64
20D
32.65
31.85
50D
33.37
31.54
100D
27.46
29.31

About Zenlabs Ethica Limited

Zenlabs Ethica Limited Share Price
ISIN
INE546F01013
Sector Market Cap
₹ 18.23 Cr

Zenlabs Ethica Limited is an India-based pharmaceutical contract manufacturing company. The Company develops, markets and exports a range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-bacterial Drugs, Nutraceuticals, and others. The Company operates in the pharmaceutical’s formulations segment, which primarily includes marketing and distribution of pharmaceutical products. Its divisions include Zenlabs, Coles Pharma and Mega Star. Its product categories include analgesics & anti-inflammatory, skin preparations, neurological disorders, eye, ear and nasal drops, anti-diabetic, anti-depressant, anti-infective, anti-emetic, steroid and anabolic steroids, antihypertensive drugs, anti-allergic, anti-cold and cough syrup, nutraceuticals, antacid, enzymes and appetite stimulant, ayurvedic preparation, git disorders, soap, and other pharmaceutical drugs. Its brands include RBC Red Super Active and Zenovit.

Zenlabs Ethica Limited Financial Highlights

  • Revenue: Zenlabs Ethica Limited reported revenue of ₹47.10 crore in FY26 vs ₹51.47 crore in FY25. It showed a decrease of 8.49% on a yearly basis.
  • Operating Profit: Zenlabs Ethica Limited reported an operating loss of ₹1.81 crore in FY26 vs ₹0.43 crore in FY25. It showed a decrease of 520.93% on a year-on-year basis.
  • Net Profit: Zenlabs Ethica Limited reported a net loss of ₹1.94 crore in FY26 vs ₹0.27 crore in FY25. It showed a decrease of 818.52% on a yearly basis.

Zenlabs Ethica Limited Quarterly Result Highlights

  • Zenlabs Ethica Limited reported revenue of ₹10.70 crore in Mar 2026, compared with ₹12.43 crore in Dec 2025, representing a decrease of 13.92% on a quarter-on-quarter (QoQ) basis.
  • Zenlabs Ethica Limited reported an operating profit of ₹0.08 crore in Mar 2026, compared with ₹2.01 crore in Dec 2025, representing an increase of 103.98% on a quarter-on-quarter (QoQ) basis.
  • Zenlabs Ethica Limited reported a profit of ₹0.00 crore in Mar 2026, compared with ₹2.01 crore in Dec 2025, reflecting an increase of 100.00% on a QoQ basis.
  • The earnings per share (EPS) of Zenlabs Ethica Limited stood at ₹0.41 during Mar 2026.
Know more
Promoters
52.96%
FII
0.00%
Other DII
0.00%
Retail and other
47.04%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
Zenlabs Ethica Limited Share Price
Zenlabs Ethica Limited
Trading
Add Stock
Add Another

FAQs on Zenlabs Ethica Limited Share Price